CHIP: a clonal odyssey of the bone marrow niche

Wolfgang E Schleicher1, Bridget Hoag2, Marco De Dominici2

  • 1Division of Hematology, Department of Medicine, and.

Insights

Clonal hematopoiesis of indeterminate potential (CHIP) involves stem cell mutations. This review explores factors driving CHIP, including aging, inflammation, and lifestyle, linking it to diseases like cardiovascular disease and blood cancers.

Area of Science:

  • Hematology
  • Genetics
  • Aging Research

Background:

  • Clonal hematopoiesis of indeterminate potential (CHIP) is defined by somatic mutations in hematopoietic stem and progenitor cells (HSPCs).
  • CHIP is linked to increased risks of cardiovascular disease (CVD) and hematological malignancies.
  • Understanding CHIP mechanisms is crucial for early detection and intervention.

Purpose of the Study:

  • To review mechanisms driving mutant HSPC selection in the bone marrow (BM) niche.
  • To examine clonal dynamics of CHIP across the lifespan.
  • To explore systemic and lifestyle factors influencing CHIP development.

Main Methods:

  • Review of seminal and recent studies on CHIP.
  • Analysis of factors influencing hematopoietic stem cell (HSC) fitness.
  • Examination of the bone marrow niche and somatic evolution.

Main Results:

  • Mutant HSPC expansion is driven by BM niche selection.
  • CHIP clonal dynamics interact with hematopoietic development.
  • Systemic factors (inflammation, cytotoxic agents) and lifestyle (diet, exercise, stress) influence CHIP.
  • Old age is a significant driver of CHIP selection.

Conclusions:

  • CHIP pathogenesis is multifactorial, involving genetic, environmental, and age-related factors.
  • Somatic evolution in the BM niche culminates in CHIP.
  • Further research is needed to elucidate CHIP's role in disease progression.

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.0K
Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.0K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K